Lab
Asl-Den LLC
Asl-Den LLC was paid $5.40M by Medicaid between Jan 2018 and Aug 2023, across 34 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 14% of everything it billed.
33Billing provider infoASL-DEN LLC
WEST PALM BEACH, FL 33401
WEST PALM BEACH, FL 33401
33aNPI1770738650assigned 11/19/2008
33bProvider typeClinical Medical Laboratory
28Total paid$5.40M
24GClaims172,266
24DCodes billed34
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#14 of 225
Median peer was paid$74K
This provider vs. median73×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,404 | $1.38M | |
| 2019 | 53,211 | $1.77M | |
| 2020 | 54,041 | $1.87M | |
| 2021 | 15,657 | $359K | |
| 2022 | 2,588 | $16K | |
| 2023 | 365 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 14% | 23,295 | 21,778 | $752K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 12% | 23,230 | 21,713 | $664K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 11% | 20,630 | 19,181 | $619K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 9.9% | 6,829 | 6,559 | $536K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 7.4% | 24,035 | 22,972 | $402K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 6.8% | 13,836 | 12,921 | $366K |
| 87482 | 6.2% | 7,051 | 6,559 | $336K | |
| 87481 | 5.5% | 10,663 | 6,435 | $297K | |
| 87512 | 5.1% | 7,495 | 6,986 | $274K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5.0% | 3,121 | 2,876 | $272K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3.8% | 5,753 | 3,798 | $206K |
| 87653 | 3.6% | 5,867 | 5,692 | $195K |
22 more codes
| 87511 | 3.1% | 5,056 | $167K | |
| 87799 | 1.5% | 2,358 | $82K | |
| 87081 | <1% | 6,544 | $52K | |
| 88141 | <1% | 3,162 | $47K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 775 | $34K |
| 87625 | <1% | 528 | $21K | |
| 87150 | <1% | 619 | $20K | |
| 87529 | <1% | 457 | $15K | |
| 86769 | <1% | 289 | $12K | |
| 88185 | <1% | 29 | $10K | |
| 88275 | <1% | 55 | $8K | |
| 88342 | <1% | 203 | $8K | |
| 88271 | <1% | 55 | $3K | |
| 88304 | <1% | 42 | $1K | |
| 88184 | <1% | 29 | $911.93 | |
| 88313 | <1% | 42 | $679.57 | |
| 88291 | <1% | 43 | $596.84 | |
| 88341 | <1% | 16 | $477.52 | |
| 85060 | <1% | 28 | $439.02 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 42 | $362.50 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 48 | $250.00 |
| 88311 | <1% | 41 | $210.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPAPAIOANU, ATHANASSIOS (CEO/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| App-Ecp, LLC | Wilson, NC | $2.05M |
| Cedar Diagnostics, LLC | Cortez, CO | $655K |
| Lab Alliance LLC | Carrollton, TX | $460K |
| Path Alliance INC | Carrollton, TX | $238K |
| Alex R. Cudkowicz, M.D.,P.C. | Cortez, CO | $76K |
| App-Pbp, LLC | West Palm Beach, FL | $16K |
| Ariana Diagnostics, LLC | Nashville, TN | $11K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.